Mostdays
7 known investors
Mostdays operates Death Clock, a longevity platform that estimates users' life expectancy based on clinical studies, bloodwork, and health habits, and provides personalized longevity plans curated by doctors. It offers lab testing through Quest and Labcorp locations and a system that updates recommendations as users' habits and bloodwork change.
Also known as Death Clock · Deathclock.co · Most Days · Most Days, Inc.
Investors · 7
Also in the syndicate · 4
Company profile
researched Aug 2026Most Days, Inc., doing business as Deathclock (deathclock.co), operates a consumer longevity platform marketed as Death Clock. Users answer 29 questions to receive an instant life expectancy estimate that the company says is powered by more than 1,200 clinical longevity studies. The estimate functions as a baseline that is refined as users sync blood test results and wearable data. The company offers three blood test panels, with a Baseline panel priced at under $100, designed by its Clinical Board and schedulable at Quest and Labcorp locations across the United States. Results feed into a personalized longevity plan generated by the company's AI, trained on its Clinical Board's framework, covering supplements, medications and early cancer screenings, which the company positions as intended to add 10-15 healthy years of life. The product component described as "The Life Lab" is presented as a system that updates as habits and bloodwork change.
The company previously operated as Most Days, a subscription-based life improvement platform for mental, physical and emotional wellness. That product, launched in alpha in December 2020 from San Francisco, let members follow or create daily routines built by medical experts and other members, covering areas such as depression, anxiety, addiction, obsessive-compulsive disorder, stress, sleep, relationships and general wellness. It combined habit tracking with an opt-in social layer in which members chose whether to keep routines private or share them with an invited support network for accountability, drawing on cognitive behavioral therapy elements and behavior-change frameworks associated with peer support groups. At launch the app was available on iOS with Android planned. Expert contributors of routines included psychologist Joan Davidson, neuroscientist Alex Korb, psychologist Britney Blair and Antoinette Giedzinska of Sierra Tucson.
Founding story
Most Days was founded by Brent Franson, who served as founder and CEO and described the product as an outgrowth of a personal system he had built for himself to improve his health and quality of life; the release describes him as a serial entrepreneur who started his first company in high school.
Business model
The Death Clock offering combines a free or low-cost life-expectancy assessment with paid blood test panels (a Baseline panel priced under $100, plus two other panels) and a personalized longevity plan; the site references a pricing page and account sign-in, and a free blood test offer. The earlier Most Days product was described as a subscription-based platform, with the alpha released to early users without charge.
Revenue is associated with paid blood test panels and platform access; the predecessor Most Days product was subscription-based. Payments are processed through Stripe and Apple.
Traction
The company states that over one million people in more than 100 countries use Death Clock, and that blood tests can be scheduled at Quest and Labcorp locations (cited as 4,500 locations in one place and 4,200 Quest locations in another).
Latest developments
As of the August 2025 privacy policy update and 2025 site content, the company operates as Most Days, Inc. dba Deathclock, offering three blood test panels, wearable and lab data integration, and AI-generated longevity plans, and states a mission of helping 100 million people live 10 years longer.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company describes Death Clock as the world's leading longevity platform, citing over one million users in more than 100 countries and coverage in Bloomberg, The Washington Post, Fox News, Daily Mail and The Colbert Report.
The company positions the offering around an evidence-referenced life expectancy estimate that updates continuously from bloodwork and wearable data, panels designed by an internal Clinical Board, and a privacy stance of encrypting health data and not selling it. The earlier Most Days product differentiated on member-controlled, invitation-based social support rather than an open social network.
Technology
The platform generates a life-expectancy estimate from a 29-question intake, referencing over 1,200 clinical longevity studies, and updates it as users connect blood test results and wearable data through what the company calls a real-time health loop. Data can be imported from third-party health tracking apps such as Apple Health and Google Fit with user permission. An AI system trained on the framework defined by the company's Clinical Board produces individualized longevity plans. The company states it encrypts user health data and does not sell it, and does not use third-party health tracking app data for advertising.
Go-to-market
Direct-to-consumer via the Death Clock website and mobile application, with a free life-expectancy assessment and a free blood test offer as entry points, supported by a podcast, press coverage and social media channels. Blood test fulfillment relies on scheduling at Quest and Labcorp locations. The predecessor Most Days app launched via the Apple App Store to alpha users.
Consumers interested in longevity, life expectancy measurement and preventive health, reached in the U.S. through national lab networks; the earlier Most Days product targeted individuals tracking mental and physical health habits.
Geography
Headquartered in San Francisco at the time of the 2020 Most Days launch; blood testing is offered at Quest and Labcorp locations across all 50 U.S. states, and the company reports users in over 100 countries.
History
The company launched the Most Days habit and wellness platform in alpha in December 2020, backed by a $3.2 million seed round. It subsequently operates as Most Days, Inc. doing business as Deathclock, running the Death Clock longevity platform; its privacy policy was last updated in August 2025 and site content carries a 2025 copyright.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsMost Days disclosed a $3.2 million seed round led by Freestyle.vc, Harrison Metal, Village Global and several angel investors to build the product.
$3.2M source ↗
Most Days launched its life improvement platform for mental, physical and emotional wellness to alpha users, available in the Apple App Store with Android planned, featuring expert-developed routines and opt-in social support.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Mostdaysmostdays.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Mostdays do?
- Most Days, Inc. operates Death Clock, a longevity platform giving life-expectancy estimates, blood testing and personalized health plans.
- Who are Mostdays's investors?
- Mostdays's investors include King River Capital, Origin Ventures, Cake Ventures.